189 related articles for article (PubMed ID: 34319007)
21. Genome-Wide Analysis of A-to-I RNA Editing.
Savva YA; Laurent GS; Reenan RA
Methods Mol Biol; 2016; 1358():255-68. PubMed ID: 26463388
[TBL] [Abstract][Full Text] [Related]
22. Prognostic analysis and risk assessment based on RNA editing in hepatocellular carcinoma.
Shi X; Bu X; Zhou X; Shen N; Chang Y; Yu W; Wu Y
J Appl Genet; 2024 Jan; ():. PubMed ID: 38217666
[TBL] [Abstract][Full Text] [Related]
23. Mammalian conserved ADAR targets comprise only a small fragment of the human editosome.
Pinto Y; Cohen HY; Levanon EY
Genome Biol; 2014 Jan; 15(1):R5. PubMed ID: 24393560
[TBL] [Abstract][Full Text] [Related]
24. ADARs and editing: The role of A-to-I RNA modification in cancer progression.
Fritzell K; Xu LD; Lagergren J; Öhman M
Semin Cell Dev Biol; 2018 Jul; 79():123-130. PubMed ID: 29146145
[TBL] [Abstract][Full Text] [Related]
25. GPEdit: the genetic and pharmacogenomic landscape of A-to-I RNA editing in cancers.
Ruan H; Li Q; Liu Y; Liu Y; Lussier C; Diao L; Han L
Nucleic Acids Res; 2022 Jan; 50(D1):D1231-D1237. PubMed ID: 34534336
[TBL] [Abstract][Full Text] [Related]
26. Genome-wide identification and characterization of tissue-specific RNA editing events in D. melanogaster and their potential role in regulating alternative splicing.
Mazloomian A; Meyer IM
RNA Biol; 2015; 12(12):1391-401. PubMed ID: 26512413
[TBL] [Abstract][Full Text] [Related]
27. Biological significance of RNA editing in cells.
Tang W; Fei Y; Page M
Mol Biotechnol; 2012 Sep; 52(1):91-100. PubMed ID: 22271460
[TBL] [Abstract][Full Text] [Related]
28. A disrupted RNA editing balance mediated by ADARs (Adenosine DeAminases that act on RNA) in human hepatocellular carcinoma.
Chan TH; Lin CH; Qi L; Fei J; Li Y; Yong KJ; Liu M; Song Y; Chow RK; Ng VH; Yuan YF; Tenen DG; Guan XY; Chen L
Gut; 2014 May; 63(5):832-43. PubMed ID: 23766440
[TBL] [Abstract][Full Text] [Related]
29. A-to-I RNA editing and cancer: from pathology to basic science.
Gallo A; Galardi S
RNA Biol; 2008; 5(3):135-9. PubMed ID: 18758244
[TBL] [Abstract][Full Text] [Related]
30. RNA editome imbalance in hepatocellular carcinoma.
Qi L; Chan TH; Tenen DG; Chen L
Cancer Res; 2014 Mar; 74(5):1301-6. PubMed ID: 24556721
[TBL] [Abstract][Full Text] [Related]
31. Combinatory RNA-Sequencing Analyses Reveal a Dual Mode of Gene Regulation by ADAR1 in Gastric Cancer.
Cho CJ; Jung J; Jiang L; Lee EJ; Kim DS; Kim BS; Kim HS; Jung HY; Song HJ; Hwang SW; Park Y; Jung MK; Pack CG; Myung SJ; Chang S
Dig Dis Sci; 2018 Jul; 63(7):1835-1850. PubMed ID: 29691780
[TBL] [Abstract][Full Text] [Related]
32. CDK13 RNA Over-Editing Mediated by ADAR1 Associates with Poor Prognosis of Hepatocellular Carcinoma Patients.
Dong X; Chen G; Cai Z; Li Z; Qiu L; Xu H; Yuan Y; Liu XL; Liu J
Cell Physiol Biochem; 2018; 47(6):2602-2612. PubMed ID: 29996118
[TBL] [Abstract][Full Text] [Related]
33. Construction and Validation of Prognostic Regulation Network Based on RNA-Binding Protein Genes in Lung Squamous Cell Carcinoma.
Zhao S; Liu Q; Li J; Hu C; Cao F; Ma W; Gao J
DNA Cell Biol; 2021 Dec; 40(12):1563-1583. PubMed ID: 34931870
[TBL] [Abstract][Full Text] [Related]
34. Deciphering miRNAs' Action through miRNA Editing.
Correia de Sousa M; Gjorgjieva M; Dolicka D; Sobolewski C; Foti M
Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31835747
[TBL] [Abstract][Full Text] [Related]
35. EndoVIPER-seq for Improved Detection of A-to-I Editing Sites in Cellular RNA.
Knutson SD; Heemstra JM
Curr Protoc Chem Biol; 2020 Jun; 12(2):e82. PubMed ID: 32469473
[TBL] [Abstract][Full Text] [Related]
36. In cancer, A-to-I RNA editing can be the driver, the passenger, or the mechanic.
Ganem NS; Ben-Asher N; Lamm AT
Drug Resist Updat; 2017 May; 32():16-22. PubMed ID: 29145975
[TBL] [Abstract][Full Text] [Related]
37. Systematic identification of A-to-I editing associated regulators from multiple human cancers.
Gu T; Fu AQ; Bolt MJ; Zhao X
Comput Biol Med; 2020 Apr; 119():103690. PubMed ID: 32339124
[TBL] [Abstract][Full Text] [Related]
38. CircNEIL3 regulatory loop promotes pancreatic ductal adenocarcinoma progression via miRNA sponging and A-to-I RNA-editing.
Shen P; Yang T; Chen Q; Yuan H; Wu P; Cai B; Meng L; Huang X; Liu J; Zhang Y; Hu W; Miao Y; Lu Z; Jiang K
Mol Cancer; 2021 Mar; 20(1):51. PubMed ID: 33750389
[TBL] [Abstract][Full Text] [Related]
39. Systematic analysis reveals cis and trans determinants affecting C-to-U RNA editing in Arabidopsis thaliana.
Chu D; Wei L
BMC Genet; 2020 Sep; 21(1):98. PubMed ID: 32883207
[TBL] [Abstract][Full Text] [Related]
40. RNA Editing Modulates Human Hepatic Aryl Hydrocarbon Receptor Expression by Creating MicroRNA Recognition Sequence.
Nakano M; Fukami T; Gotoh S; Takamiya M; Aoki Y; Nakajima M
J Biol Chem; 2016 Jan; 291(2):894-903. PubMed ID: 26601943
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
